Cardiac Emergencies Perspective

 
 
  • Heart Defibrillators in CKD: More Harm Than Good? Dr Bansal comments on her study on heart defibrillators in patients with kidney disease and the greater risk for hospitalization for heart failure.
  • 7 Cardiology Trials to Look for in 2018   Trials on PCSK9 inhibitors, antiplatelets, anticoagulants, and even catheter ablation of atrial fibrillation are among Drs Harrington and Gibson's picks for what to look for in 2018.
  • Artificial Intelligence in Cardiology: Friend or Foe?   Dr Turakhia reassures Dr Mandrola that true AI learns 'on the job' and will be a lot better than current computer-read ECGs.
  • To Err Is Homicide in Britain: The Case of Dr Bawa-Garba Saurabh Jha, a US-based, British-trained medic who worked in the NHS for 4 years, discusses the case of a UK trainee pediatrician convicted of homicide for the death of a child from sepsis.
  • Did Grey's Anatomy Get It Right for Women With Heart Disease? An episode of the hospital drama featured a female surgeon having a heart attack but meeting disbelief (including her own) along the way. TV critic and cardiologist Dr Walton-Shirley gives her review.
  • Inspired Medicine: Getting Patients to Make Healthy Changes Physicians must lead a change in culture, inside and outside of their practices, according to Dr Bert Mandelbaum.
  • Three Must-Read EM Articles From 2017 Dr Amal Mattu discusses his picks for the most important emergency medicine literature of the past year. What are your picks?
  • Can RNs Bolus Propofol? Nurses often titrate deep sedation, but can they push these drugs if ordered to do so?
  • Should You Honor a DNR Tattoo?   If an incapacitated patient has a 'do not resuscitate' request tattooed on his or her body, should a physician comply with the request?
  • The Top Cardiology Trials of 2017 in Review   In this annual tradition, Drs Harrington and Gibson discuss their picks for the top cardiology trials of the year, covering PCSK9 inhibitors, anti-inflammatory and anthithrombotic drugs, and PCI.
  • Revascularization in CS: Keep It Simple and Get Out of Dodge   Drs Harrington, Batchelor, and O'Donoghue discuss the implications of the TCT late-breaking CULPRIT SHOCK trial testing culprit-only vs multivessel revascularization in unstable patients in cardiogenic shock.
  • With Sudden Death, Don't Automatically Blame the Heart   Drs Gayatri Acharya, Michael Ackerman, and Peter Noseworthy discuss the importance of investigating sudden deaths in light of new research showing that many presumed sudden cardiac deaths are not cardiac in origin.
  • The High Cost of Public Reporting A high-risk patient needed surgery, but Dr Koka couldn't find a surgeon willing to operate on him, for fear of looking bad on publically reported outcomes data.
  • CASTLE-AF: Ablate Patients With HF Before It's too Late?   Dr Mandrola interviews the lead investigator of CASTLE-AF trial on catheter ablation in patients with heart failure and atrial fibrillation, presented at the European Society of Cardiology Congress.
  • Is Hypothermia Effective in Acute Neurologic Conditions? Dr Andrew Wilner speaks with the author behind the AAN's new guideline on hypothermia's role in post-cardiac arrest neuroprotection.
  • Domperidone for Gastroparesis: Beware of Drug Interactions Use of domperidone requires special monitoring of drug interactions and cardiac function. According to new research, we need to do better, says Dr David Johnson.
  • FDA Safety Labeling Changes: April-June 2017 Summaries of safety labeling changes and boxed warning highlights approved by the FDA for the second quarter of 2017 are presented.
  • ESC Mandrola's ESC 2017 Preview: Some Truly 'Hot' Hotlines The 2017 European Society of Cardiology Congress has some potentially groundbreaking trials on inflammation, AF, screening, and the possible resurrection of CETP inhibitors and renal denervation.
  • Notes From a Most Unusual Critical Care Conference Metallica and drones aren't things you'd expect at a medical conference. EM doc Christopher Tedeschi summarizes key takeaways from Social Media and Critical Care, a conference held in Berlin in June.
  • Do ICDs Have a Role in Nonischemic Cardiomyopathy?   Drs Naveen Pererira, Paul Friedman, and Abhishek Deshmukh discuss how clinical trials have shaped preferences for pacemakers, defibrillators, and optimal medical therapy in the treatment of nonischemic cardiomyopathy.